RecruitingNot ApplicableNCT06360627

Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT


Sponsor

University of Zurich

Enrollment

100 participants

Start Date

Feb 20, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Evaluation of ultra low dose protocols and Iomeron 400 contrast in PCD-CT


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether ultra-low-dose CT scans — which use much less radiation than standard CT — combined with a specific contrast agent (Iomeron 400) can produce high-quality images using new photon-counting detector CT (PCD-CT) technology. The goal is to detect lung nodules and pneumonia with less radiation exposure. **You may be eligible if...** - You are 18 or older - You have been referred for a CT scan to evaluate a lung nodule or check for pneumonia - Your BMI is 30 or below **You may NOT be eligible if...** - You are under 18 years old - Your BMI is over 30 Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONComputed Tomography

Computed Tomography CHEST


Locations(1)

University Hospital Zurich - Diagnostic Radiology

Zurich, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06360627


Related Trials